Top Markets
Coin of the day
OmniAb, Inc. OmniAb, Inc.

OmniAb, Inc.

OABI
Classement en actions #11871
OmniAb, Inc. is an American biotechnology firm focused on pioneering... OmniAb, Inc. is an American biotechnology firm focused on pioneering therapeutic antibody discovery. The company provides a sophisticated platform that allows its industry partners to access a broad spectrum of antibody repertoires and advanced screening techniques, thereby facilitating the development of next-generation treatments. Central to the OmniAb platform is the unique biological capability of proprietary genetically engineered animals, such as OmniRat, OmniChicken, and OmniMouse. These animals are modified to produce human-sequence antibodies, simplifying the creation of human therapeutic candidates. Additionally, OmniAb offers specialized technologies like OmniFlic (a transgenic rat) and OmniClic (a transgenic chicken), which address the requirements for bispecific antibody applications via a common light chain method, as well as OmniTaur, which leverages the distinct structural properties of cow antibodies for challenging targets. The company was founded in 2012 and is based in Emeryville, California.
Prix de l'action
$4.48
Dernière synchronisation: 2026-08-28
Capitalisation boursière
$649.33M
Changement (1 jour)
-2.84%
Changement (1 an)
179.94%
Pays
US
Échange OmniAb, Inc. (OABI)

Catégorie

Historique du prix de l'action pour OmniAb, Inc. (OABI)
Prix de clôture le plus élevé : $3.89 le 2026-08-01

Prix de clôture le plus bas : $9.76 le 2021-09-01
Historique du prix de l'action de OmniAb, Inc. de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 1.00%
2025 -47.69%
2024 -30.70%
2023 49.25%
2022 -63.59%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH